A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus

NCT04999787 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Pruritus

Interventions

DRUG: HSK21542
DRUG: Placebo

Sponsor

Haisco Pharmaceutical Group Co., Ltd.